| 胃肝样腺癌患者的临床特点与诊治(附1例临床病例)周达1,韩晶2,李锋1* |
| |
| 引用本文： | 周达,韩晶,李锋.胃肝样腺癌患者的临床特点与诊治(附1例临床病例)周达1,韩晶2,李锋1*[J].中国临床医学,2021,28(S1). |
| |
| 作者姓名： | 周达 韩晶 李锋 |
| |
| 作者单位： | 复旦大学附属中山医院,复旦大学附属中山医院,复旦大学附属中山医院 |
| |
| 基金项目： | 国家自然科学基金（青年基金）（项目号81800510）；上海市青年科技英才扬帆计划（18YF1415900） |
| |
| 摘 要： | 目的 探讨胃肝样腺癌(hepatoid adenocarcinoma of stomach, HAS)患者的临床特点、诊治方法。方法 分析1 例胃肝样腺癌患者的临床资料,结合国内外文献进行分析讨论。结果与结论 HAS易被误诊,拥有独特的临床病理特征,与普通型胃癌相比,预后更差。早期进行pTNM分期、手术治疗和辅助化疗可能对改善疾病预后更有利。对于淋巴结转移或/和术前远端转移的患者强烈推荐新辅助疗法。
|
| 关 键 词： | 胃 肝样腺癌 甲胎蛋白 |
| 收稿时间： | 2020/12/24 0:00:00 |
| 修稿时间： | 2021/3/24 0:00:00 |
Clinical features, diagnosis and treatment of patients with hepatoid adenocarcinoma of the stomach (with 1 clinical case)Da Zhou1, Jing Han2, Feng Li1* |
| |
| Zhou D,Han Jing and Li Feng.Clinical features, diagnosis and treatment of patients with hepatoid adenocarcinoma of the stomach (with 1 clinical case)Da Zhou1, Jing Han2, Feng Li1*[J].Chinese Journal Of Clinical Medicine,2021,28(S1). |
| |
| Authors: | Zhou D Han Jing and Li Feng |
| |
| Institution: | Zhongshan Hospital, Fudan University,Zhongshan Hospital, Fudan University,Zhongshan Hospital, Fudan University |
| |
| Abstract: | Objective To investigate the clinical characteristics, diagnosis and treatment of patients with hepatoid adenocarcinoma of the stomach (HAS). Methods The clinical data of a patient with HAS was analyzed, and then discussed in combination with domestic and foreign literatures. Results and Conclusions HAS, which is easy to be misdiagnosed, has unique clinicopathological characteristics with a worse prognosis compared with ordinary gastric cancer. Early pTNM staging, surgical treatment and adjuvant chemotherapy may improve the prognosis of HAS. Neoadjuvant therapy is strongly recommended for patients with lymph node metastasis or/and distant metastasis before surgery. |
| |
| Keywords: | Stomach Hepatoid adenocarcinoma alpha-fetoprotein |
|
| 点击此处可从《中国临床医学》浏览原始摘要信息 |
| 点击此处可从《中国临床医学》下载免费的PDF全文 |
|
